Personalized heart failure treatment using biomarkers
Part of Heart & circulation clinical trials.
This study tests whether a blood test can help doctors choose the best medication for people with chronic heart failure. It aims to improve symptom control and reduce hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with heart failure for at least 3 months and have symptoms.
- You take at least 40 mg of furosemide (or a similar water pill) daily to control symptoms.
- You have been in the hospital for heart failure recently, or have high levels of a heart stress hormone (BNP or NT-proBNP) in your blood.
- You do not have recent heart surgery, a heart attack, or a stroke in the last month.
- You are not pregnant, on dialysis, or have severe liver disease with fluid buildup in the belly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This study looks at how doctors adjust heart failure medications and uses simple blood tests (biomarkers) to see how well you respond. It aims to help fine-tune your treatment so you feel better and avoid hospital stays.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
This trial tests a multidisciplinary care approach aimed at helping people with high risk for heart failure get diagnosed earlier. It may help you catch heart failure sooner if it starts, so treatment can begin earlier.
This study tests whether checking a blood test (NT-proBNP) at the bedside in the heart intensive care unit helps doctors monitor how well treatment is working for people admitted with acute heart failure. The aim is to improve care for patients with fluid buildup (congestion).
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
Hear when a new Congestive Heart Failure(CHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.